Argenx
ARGX
#429
Rank
NZ$100.21 B
Marketcap
NZ$1,602
Share price
8.56%
Change (1 day)
68.36%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company